Sutib Tablet 50 mg contains Sunitinib, a potent oral tyrosine kinase inhibitor (TKI) used in targeted cancer therapy. It is designed to inhibit tumor growth and angiogenesis (formation of new blood vessels that feed tumors), making it effective for advanced or metastatic cancers. Sutib 50 mg is commonly prescribed for renal cell carcinoma (RCC), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET). Its oral formulation allows convenient once-daily dosing for long-term management of cancer.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Uses and Benefits

• Renal Cell Carcinoma (RCC): Reduces tumor progression in advanced kidney cancer.

• Gastrointestinal Stromal Tumors (GIST): Effective for patients resistant or intolerant to imatinib.

• Pancreatic Neuroendocrine Tumors (pNET): Helps control disease progression in advanced cases.

• Targeted Therapy: Blocks specific tyrosine kinases that drive tumor growth and angiogenesis.

• Oral Dosing Convenience: Provides flexible, once-daily administration for outpatient cancer therapy.

Mechanism of Action

Sunitinib inhibits multiple receptor tyrosine kinases (RTKs), including:

• VEGFR (Vascular Endothelial Growth Factor Receptor) – reduces tumor blood vessel formation.

• PDGFR (Platelet-Derived Growth Factor Receptor) – disrupts tumor growth signaling.

• KIT, FLT3, RET – involved in tumor cell proliferation and survival.

By blocking these pathways, Sunitinib reduces tumor vascularization, slows growth, and promotes cancer cell death.

Dosage and Administration

• Administration: Take orally with or without food. Swallow the tablet whole; do not crush or chew.

• Dosage: 50 mg is typically the standard starting dose for adults, administered once daily for a prescribed number of weeks (commonly 4 weeks on treatment followed by 2 weeks off, depending on the cancer type and regimen).

• Monitoring: Requires regular blood tests, liver function checks, blood pressure monitoring, and cardiac evaluation to ensure safety.

Precautions and Safety Information

• Medical History: Inform your doctor if you have liver or kidney impairment, heart disease, hypertension, bleeding disorders, or prior heart failure.

• Pregnancy and Lactation: Contraindicated; effective contraception is required during and after treatment.

• Drug Interactions: Avoid strong CYP3A4 inhibitors or inducers unless directed by your physician.

• Activity Caution: May cause fatigue, dizziness, or visual disturbances; caution when driving or operating machinery.

Possible Side Effects

Sutib Tablet 50 mg may cause:

• Fatigue, weakness, or headache

• Nausea, vomiting, diarrhea, or constipation

• Hypertension or palpitations

• Skin changes, hand-foot syndrome, or rash

• Rare liver toxicity, bleeding events, or heart complications

Side effects are typically manageable with dose adjustments and close medical supervision.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

• Store below 30°C in a cool, dry place.

• Keep in the original packaging to protect from moisture and light.

• Keep out of reach of children.

Sutib Tablet 50 mg provides potent, targeted therapy for managing advanced cancers, slowing tumor growth, controlling disease progression, and improving patient outcomes when used under strict medical supervision.